France
· Delayed Price · Currency is EUR GenSight Biologics Statistics
Total Valuation
EPA:SIGHT has a market cap or net worth of EUR 28.97 million. The enterprise value is 45.62 million.
| Market Cap | 28.97M |
| Enterprise Value | 45.62M |
Important Dates
The last earnings date was Wednesday, March 19, 2025.
| Earnings Date | Mar 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
EPA:SIGHT has 128.18 million shares outstanding. The number of shares has increased by 98.28% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 128.18M |
| Shares Change (YoY) | +98.28% |
| Shares Change (QoQ) | +31.54% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 11.94% |
| Float | 71.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.25 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.26 |
| EV / Sales | 17.38 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.24
| Current Ratio | 0.24 |
| Quick Ratio | 0.11 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.54 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -99.39% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 133.32% |
| Revenue Per Employee | 238,636 |
| Profits Per Employee | -1.27M |
| Employee Count | 16 |
| Asset Turnover | 0.26 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.15% in the last 52 weeks. The beta is 2.24, so EPA:SIGHT's price volatility has been higher than the market average.
| Beta (5Y) | 2.24 |
| 52-Week Price Change | -45.15% |
| 50-Day Moving Average | 0.26 |
| 200-Day Moving Average | 0.31 |
| Relative Strength Index (RSI) | 38.57 |
| Average Volume (20 Days) | 223,251 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EPA:SIGHT had revenue of EUR 2.63 million and -14.00 million in losses. Loss per share was -0.15.
| Revenue | 2.63M |
| Gross Profit | 2.63M |
| Operating Income | -15.81M |
| Pretax Income | -13.98M |
| Net Income | -14.00M |
| EBITDA | -14.76M |
| EBIT | -15.81M |
| Loss Per Share | -0.15 |
Balance Sheet
The company has 2.46 million in cash and 19.11 million in debt, giving a net cash position of -16.65 million or -0.13 per share.
| Cash & Cash Equivalents | 2.46M |
| Total Debt | 19.11M |
| Net Cash | -16.65M |
| Net Cash Per Share | -0.13 |
| Equity (Book Value) | -26.92M |
| Book Value Per Share | -0.25 |
| Working Capital | -17.28M |
Cash Flow
| Operating Cash Flow | -12.94M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -602.44% |
| Pretax Margin | -532.57% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
EPA:SIGHT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -98.28% |
| Shareholder Yield | -98.28% |
| Earnings Yield | -48.33% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EPA:SIGHT has an Altman Z-Score of -7.81. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.81 |
| Piotroski F-Score | n/a |